UVV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses Minerva Neurosciences Inc NERV Q1 2026 Earnings Wider Loss Highlights Ongoing PreRevenue Development Stage MT Q1 2026 Earnings Modest EPS Beat Amid Revenue Uncertainty BRLT Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain ATHM Q4 2025 Earnings Narrow EPS Miss Sends Stock Slightly Lower